By: Michael Furrow , DLA Piper, and Whitney Meier , Venable LLP The Biologics Price Competition and Innovation Act (BPCIA) provides an abbreviated pathway for companies to bring biologic drugs to market that are biosimilar to previously approved branded...

By: Rebecca G. DiStefano , GREENBERG TRAURIG, P.A. Overview The U.S. economy was spotlighted during an unprecedented national Presidential election in 2016 with campaign debate focused on the preservation and initiation of new jobs. This topic, of...

By: David Azarkh and John O’Connell , Simpson Thacher & Bartlett LLP. Overview: The High Yield Roller Coaster Continues The most appropriate word to describe the high yield market in 2016 is volatility. There were some rough patches when...

By: Breia L. Schleuss and Rachael Dettmann Spiegel, Faegre Baker Daniels LLP THE FOOD SAFETY MODERNIZATION ACT (FSMA) REPRESENTS one of the most sweeping and substantial changes to U.S. food safety laws in over 70 years. After years of delays in publishing...

By: Annemargaret Connolly and Thomas D. Goslin , Weil, Gotshal & Manges LLP Climate change is arguably the most high-profile and rapidly evolving environmental issue facing the global business community today. Governments of nearly every nation...